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Transcription of the human immunodeficiency virus type 1 (HIV-1) genome takes place after integration of the provirus
into human chromosomal DNA. HIV transcription is known to be modulated by viral and cellular factors but the influence
of flanking chromosomal sequences on proviral gene expression has not been well defined. To investigate the activity of
the integrated HIV promoter, we exploited the ability of recombinant adeno-associated virus (AAV-2) to transfer and stably
integrate genes into the human genome at random or site-specifically. Chimeric AAV vectors were constructed containing
an HIV-CAT reporter cassette; some vectors also contained the neomycin resistance gene to facilitate the isolation of
positive clones. HeLa cells were infected with recombinant AAV, in some instances together with wild-type virus as a source
of AAV rep function. We isolated 25 clones of G418-resistant cells which carried the integrated HIV-CAT cassette, generally
occupying unique sites that did not correspond to the AAV-specific region of chromosome 19. The HIV promoter was
transcriptionally active in most of the clones. Basal promoter activity varied substantially among the clones, and its responsiv-
ity to the HIV transactivator Tat was also variable. The integrated HIV promoter was transactivated to comparable degrees
by the one-exon form and two-exon form of Tat. These findings provide evidence that the transcriptional activity of the HIV
promoter can be greatly influenced by the site of proviral insertion. q 1997 Academic Press
INTRODUCTION factors. Transcription from the viral promoter located in
the integrated long terminal repeat (LTR) is activated by
Human immunodeficiency virus type 1 (HIV-1) predom- host cell factors such as cytokines and cellular transacti-
inantly infects CD4/ immune cells such as T-lympho- vators, leading to synthesis of HIV regulatory proteins,
cytes and macrophages (Staprans, 1994). The viral RNA Tat and Rev, which in turn enhance the expression of
genome is converted into a DNA intermediate that subse- viral genes required for a productive infection (Bednarik
quently integrates into chromosomal DNA. Integration is and Folks, 1992; Nabel, 1993; Zagury et al., 1986). The
essential for stable maintenance, gene expression, and Tat protein interacts with its target RNA binding se-
pathogenicity of the virus (Bednarik and Folks, 1992). quence, the transactivation response element (TAR),
Continuous sporadic viral gene expression occurs in a
which is located in the 5* untranslated region of all HIV
small fraction of patients’ immune cells harboring the
transcripts. TAR minimally extends from residues /14 to
chromosomally integrated proviral DNA (Embretson et /44 relative to the cap site at /1, forming a stem-loop
al., 1993; Pantaleo et al., 1993). Such chronic viral persis-
structure that binds Tat as well as cellular factors (Pe-
tence appears to dampen immune surveillance by grad-
terlin et al., 1993). These interactions among Tat, TAR,ual attrition of T-lymphocytes and ultimately causes im-
and cellular factors increase transcriptional initiation andmune cell depletion culminating in the onset of AIDS
elongation by RNA polymerase II complexes from the(Embretson et al., 1993; Pantaleo et al., 1993). Further-
LTR (Kao et al., 1987; Laspia et al., 1990; Sheridan et al.,more, the degree of HIV pathogenicity is apparently di-
1993). Rev, on the other hand, interacts with a separaterectly proportional to the level of viral gene expression
RNA structure to facilitate the cytoplasmic accumulationfrom the chromosomally integrated HIV provirus (Panta-
of viral mRNAs that encode structural proteins (Malim etleo et al., 1993).
al., 1989).Expression of HIV genes is influenced by numerous
Circumstantial evidence suggests that the activity of
the HIV promoter can also be influenced by the site of
proviral integration and chromatin organization (Almouzni1 Current address: Ribozyme Pharmaceuticals Inc., Boulder, CO
80301. E-mail: nahreip@rpi.com. et al., 1991; Kornberg and Lorch, 1992; Lint et al., 1994;
2 To whom correspondence and reprint requests should be ad- Verdin et al., 1993; Wolffe, 1994). Although retroviral inte-
dressed at present address: Department of Biochemistry and Molecular gration into the host cell genome occurs with little appar-Biology, UMDNJ–New Jersey Medical School, 185 South Orange Ave-
ent target sequence specificity, HIV-1 displays a prefer-nue, Newark, NJ 07103-2714. Fax: (973) 972-5594. E-mail: mathews
@umdnj.edu. ence for sites in or near L1 and Alu repeats (Stevens
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and Griffith, 1994). In model systems, chromatin structure
seems to affect site selection, and integration reportedly
takes place preferentially in regions of chromosomal
DNA that are being actively transcribed or replicated
(Mooslehner et al., 1990; Shih et al., 1988; Vijaya et al.,
1986). Correspondingly, we and others have shown that
the transcriptional activity (both basal and Tat transacti-
vated) of the HIV promoter is stimulated by an origin of
replication (Jeang et al., 1993; Kessler and Mathews,
1991; Nahreini and Mathews, 1995). Conversely, replica- FIG. 1. Schematic drawing of recombinant AAV plasmids. Large rect-
angles represent the AAV replicase gene (REP), the AAV capsid genetion may change the organization of chromatin in a way
(CAP), the HIV LTR reporter cassette (LTR-CAT), and the neomycinthat enhances HIV promoter activity (Proudfoot et al.,
resistance chimera (TK.Neor). Small open rectangles represent AAV1992). Possibly as a reflection of such changes, the distri- termini, and small closed rectangles represent adenovirus termini.
bution of nucleosomes around the HIV promoter changes
when cells are treated with factors that increase pro-
moter activity (Verdin et al., 1993; Lint et al., 1994). cassette is flanked by AAV-termini within the pEMBL vec-
Here we test the hypothesis that the activity of the HIV tor backbone (Nahreini et al., 1993). Plasmid pWP19 was
promoter and its sensitivity to transactivation by Tat are digested to completion with BamHI and treated with alka-
influenced by the proviral integration site. To investigate line phosphatase. The HIV-LTR-CAT reporter gene cas-
the activity of HIV promoter in the context of human chro- sette was isolated from pHO (Kessler and Mathews,
mosomes, we used adeno-associated virus-2 (AAV-2) to 1991) by digestion to completion with BamHI and partial
transduce a reporter gene driven by the HIV LTR into digestion with HindIII, blunt-ended with Klenow enzyme,
chromosomal DNA. AAV is a small nonpathogenic hu- and ligated to a BamHI linker. This fragment was sub-
man parvovirus which is dependent on a helper virus, cloned into the BamHI site of pWP19 to generate con-
usually adenovirus, for productive infection (Muzyczka, structs pWP30 and pWP31 (Fig. 1). Similarly, the LTR-
1992). In the absence of helper virus, wild-type AAV DNA CAT fragment was subcloned into the BglII site of plas-
stably integrates into human chromosomal DNA and es- mid pWP25 to generate pWP28 and pWP29 (Fig. 1).
tablishes a latent infection. The viral DNA preferentially pWP25 is a derivative of psub201 (Samulski, 1987) which
integrates into a defined region of chromosome 19 with contains the full-length AAV-2 genome flanked by AAV
a frequency of up to 70% in established human cell lines inverted terminal repeats. Plasmid psub201 was di-
such as HeLa and Detroit-60 (Kotin et al., 1990, 1992; gested to completion with EcoNI and partially digested
Samulski et al., 1991; Linden et al., 1996). Specific inte- with XbaI to remove the capsid (cap) coding region. The
gration is dependent on the AAV genomic termini and resulting EcoNI–XbaI fragment was blunt-ended with
its viral replication (rep) proteins (Samulski, 1993; Weitz- Klenow enzyme and ligated to BglII linkers, generating
man et al., 1994; Kearns et al., 1996). These features the plasmid pWP25.
have made AAV an attractive viral vector for the transfer
of foreign genes into human cells (Srivastava, 1994). We Rescue and replication assay
report the generation and properties of a series of cell
lines containing the integrated HIV promoter linked to KB or 293 monolayer cultures were co-transfected with
a recombinant AAV plasmid and the helper plasmidthe chloramphenicol acetyl transferase (CAT) gene.
pAAV/Ad (Samulski et al., 1989) which contains a nonres-
cuable AAV-2 genome in which the AAV termini haveMATERIALS AND METHODS
been replaced by adenovirus termini (Fig. 1). Briefly, 2
Cell culture mg of pAAV/Ad and 2 mg of recombinant AAV plasmid
(e.g., pWP31) were mixed with a solution containing 250Monolayer cultures of HeLa cells were grown in Dul-
mg/ml DEAE-dextran (Pharmacia) per milliliter, in DMEMbecco’s modified Eagle’s medium (DMEM) plus 10% fetal
containing 0.05 M HEPES, pH 7.05, and applied to cellsbovine serum (FCS) and 100 mg of penicillin and strepto-
for 30 min at room temperature. Simultaneously, the cellsmycin per milliliter. Unless otherwise indicated, transfec-
were infected with adenovirus-2 at a multiplicity of infec-tions were carried out at 60–70% confluency.
tion (m.o.i.) of 10. Following removal of the medium, the
cells were washed twice with sterile phosphate-bufferedRecombinant AAV plasmids
saline (PBS) and incubated in fresh medium at 377 for
48 hr. Low-molecular-weight DNA from cells was isolatedPlasmid pWP19 (Nahreini et al., 1993) contains the
neomycin resistance (Neo) gene driven by the herpesvi- essentially as described by Hirt (1967). Equal amounts
of DNA were digested with DpnI, resolved by electropho-rus thymidine kinase (TK) promoter with the TK polyade-
nylation signal in its untranslated 3* region. This TK.Neo resis in a 1% agarose horizontal slab gel, and transferred
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to membrane (Genescreen plus, DuPont) for Southern fresh medium was applied. Unless otherwise indicated,
cells were harvested at 32 hr posttransfection. Transfec-blot hybridization as described previously (Nahreini and
Mathews, 1995). As expected, the rescue and replication tion of cells in 10-cm plates was carried out in the same
way with twice as much DNA. CAT and b-galactosidaseof pWP28 and pWP29 were independent of pAAV/Ad
(data not shown). To rescue recombinant AAV proviral assays were performed essentially as described pre-
viously (Morris et al., 1994; Nahreini and Mathews, 1995).DNA from neomycin-resistant clones, cells were superin-
fected with adenovirus, and low-molecular-DNA was iso- Cell extracts with high activity were diluted or incubated
for shorter times, or both, to ensure that the assay waslated and analyzed as described above.
performed in the linear range (less than 50% acetylation
Preparation of recombinant AAV of chloramphenicol). The Tat vectors were as follows:
pCMV-Tat (pBC12/CMV/t2; Cullen, 1986); pGCTat (Ratna-Twenty 10-cm plates of 293 or KB monolayer cultures
sabapathy et al., 1990); pTat2ex (Jeang et al., 1993);were co-transfected with pAAV/Ad and a recombinant
pCMV-Tat1(72R); pCMV-Tat(86R); and the empty vectorAAV plasmid (pWP28, 29, 30, or 31) using DEAE-dextran
pCMV (Rhim and Rice, 1994).and simultaneously infected with adenovirus as de-
scribed above, except that 10 mg of each plasmid was
used per plate. Cells were harvested by gentle pipetting RESULTS
at 60–65 hr posttransfection/infection when a cytopathic
effect was clearly visible. After three cycles of freezing To investigate the activity of the HIV promoter when
and thawing, the cell lysate was incubated at 567 for 1 it is integrated into the human genome at various loci,
hr to inactivate adenovirus and then centrifuged to pellet including a specific site in chromosome 19, the human
cell debris. Supernatant containing recombinant AAV parvovirus AAV-2 was used to transduce a CAT reporter
was treated with DNase (10 mg/ml) at 377 for 30 min to gene driven by the HIV LTR into chromosomal DNA. We
degrade free plasmid DNA and subsequently stored at first constructed chimeric AAV plasmids containing the0807. HIV LTR reporter gene cassette together with the gene
for AAV rep (pWP28 and 29) or for neomycin resistance
Generation of cell clones
(pWP30 and 31). The genes were inserted into the vector
in the same (pWP28, pWP31) or opposite (pWP29,HeLa monolayer culture cells at 70–80% confluency
pWP30) orientations (Fig. 1). Infectious chimeric viruseswere co-infected with recombinant AAV together with
generated from the constructs were used to introducewild-type AAV (m.o.i.  2) for 1 hr at 377. The viral inocu-
the cassettes into cells, and the resultant cell lines werelum was removed and the cells were rinsed with PBS
characterized with regard to integration site and pro-and then incubated in DMEM with 10% FCS. Cells were
moter activity.trypsinized at 60 hr postinfection and plated at lower
density in several 10-cm plates containing DMEM with
10% FCS and G418 (1 mg/ml) (Sigma Biochemicals). The Integration of HIV LTR-CAT sequences into human
medium was periodically replaced with fresh DMEM – cells
10% FCS containing G418. Neomycin-resistant colonies
appeared within 3 weeks, and individual clones were First, recombinant AAV vWP28, containing the rep
isolated as described previously (Nahreini et al., 1992). gene and LTR-CAT reporter cassette in the same orienta-
Isolated clones were passaged in the presence of G418 tion, was used to infect HeLa cells. Two days later, cells
for at least 2 weeks and then resuspended in FCS con- were cultured at low density to isolate independent
taining 10% DMSO and stored in liquid nitrogen. clones which were then assayed for the presence of the
LTR-CAT cassette. No CAT activity was detected in any
Transfections and CAT assays
of the 20 clones isolated, either in the presence or in the
absence of a Tat-expressing plasmid (data not shown).Monolayer cultures, which had been passaged the
previous day, were transfected by the calcium phosphate Concluding that it is difficult to isolate cell clones con-
taining the integrated viral genome in the absence of aprecipitation protocol (Morris et al., 1994; Nahreini and
Mathews, 1995). Each 6-cm plate of cells received 1 or selectable marker gene, we turned to the recombinant
virus vWP31 in which the neomycin-resistance gene re-5 mg of Tat vector, 1 mg of pON260 containing the b-
galactosidase gene (Cherrington and Mocarski, 1989), places the AAV rep gene. HeLa cells were infected with
vWP31 together with wild-type AAV which provides repand carrier salmon sperm DNA to a total of 20 mg DNA.
For transient expression of episomal HIV LTR-CAT, HeLa functions and may impart site-specific integration of the
recombinant virus on chromosome 19 (Kotin et al., 1990,cells were transfected with 5 mg of pWP31 in the same
way. The calcium phosphate–DNA precipitate was ap- 1992; Samulski et al., 1991; Linden et al., 1996). Genomic
DNA was prepared from 25 independent clones and ana-plied to cells and transfection was carried out for 16 hr
under 5% CO2 at 377. Cells were rinsed with PBS, and lyzed by Southern blotting as shown for 14 clones in Fig.
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on chromosome 19, an additional band (not present in
digested uninfected cell DNA) hybridizing to the chromo-
some 19-specific probe would be expected to appear at
a new position on the blot. Furthermore, the shifted band
should hybridize with both the Neo probe and the chro-
mosome 19-specific probes unless rearrangements have
taken place concomitant with integration (as frequently
observed; see Samulski et al., 1991; Kotin et al., 1992).
No shift was apparent with a majority of the clones, sug-
gesting that this region of chromosome 19 is intact, but
a shift was detected in seven cases (clones 3.1, 4.1, 5.1,
and 21; data for clones 8.1, 21, and 28 not shown) as
seen in Fig. 2B. When the two autoradiographs were
superimposed, the shifted band appeared to cohybridize
with both probes only in clone 4.1; two shifted bands
were detected in this case, presumably as a result of
chromosomal rearrangement, which is also common (Sa-
mulski et al., 1991; Kotin et al., 1992). Therefore, the re-
combinant AAV vWP31 integrated into a large number of
sites, only some of which are located at the known site
on chromosome 19.
Rescue and replication of chromosomally integrated
AAV are dependent on AAV rep proteins and adenovirus
helper functions (Muzyczka, 1992). To determine whether
any of the vWP31-derived clones contains rescuable
wild-type AAV provirus, cells were superinfected with ad-
enovirus (Nahreini et al., 1992, 1993). Low-molecular-
weight DNA was extracted and digested with DpnI to
degrade unreplicated DNA (which is methylated) and an-
alyzed by Southern blot probed with 32P-labeled AAV
DNA. Rescue and replication of the wild-type AAV provi-FIG. 2. Analysis of integration patterns in Neor clones. (A) Neo probe.
Approximately 20 mg of genomic DNA from each cell line was digested rus from four clones (5.1, 8.1, 23, and 28) were evidenced
with the restriction endonuclease HindIII, subjected to gel electropho- by detection of characteristic monomeric and dimeric
resis and blotting, and probed with a 32P-labeled Neo DNA insert. Bands
viral DNA replicative species (Fig. 3; data for clones 23were detected by autoradiography. Cell clone numbers are indicated.
(B) Chromosome 19 probe. The Neo probe was stripped from the mem-
brane which was then reprobed with the 32P-labeled chromosome 19-
specific AAV right-junction DNA fragment (Kotin et al., 1990). Sizes
of HindIII-digested l DNA fragments are indicated in kilobases. The
arrowhead marks the position of the right-junction fragment in unin-
fected HeLa cells.
2. The DNA was digested with HindIII, which cuts at the
junction between the LTR and the CAT coding sequences
but not elsewhere in the recombinant viral DNA.
The blot was probed with 32P-labeled Neo DNA to
reveal the integration pattern of the recombinant AAV in
genomic DNA from the 14 G418-resistant clones (Fig.
2A). Detection of a single band hybridizing to the Neo
probe in each lane suggests that the recombinant virus
integrated into a single site in chromosomal DNA in each FIG. 3. Rescue and replication of the integrated wild-type AAV ge-
nome from Neor clones. The cell clones indicated were superinfectedcell line. We then investigated whether any of the recom-
with adenovirus. Low-molecular-weight DNA was isolated at 48 hr post-binant viruses had targeted chromosome 19, by stripping
infection/transfection, digested with DpnI, separated by gel electropho-the Neo probe from the blot and rehybridizing with a
resis, blotted, and probed with 32P-labeled AAV DNA. D and M denote
chromosome 19 probe containing sequences from the the dimeric and monomeric replicative forms of recombinant AAV DNA,
cellular AAV integration site. If the recombinant proviral respectively. Sizes of HindIII-digested l DNA marker fragments are
indicated in kilobases.DNA is integrated at the specific AAV integration site
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liquid nitrogen. These data indicate that the basal HIV-
LTR promoter activity varies significantly among the lines,
possibly influenced by the site of proviral integration.
To investigate the effect of the HIV Tat protein on the
activity of the integrated HIV promoter, the clones were
transfected with one of two different Tat expression vec-
tors driven by the cytomegalovirus (CMV) immediate
early promoter. The plasmid pCMV-Tat encodes the one-
exon form of the protein, Tat72, whereas pCGTat en-
codes the two-exon form, Tat86. Transient expression of
either Tat72 or Tat86 dramatically increased the CAT
enzyme activity in the majority of clones (Fig. 5). Clones
that showed no detectable basal promoter activity also
failed to respond to Tat transactivation and may not con-
tain the LTR-CAT cassette intact. The degree of Tat-in-
duced transactivation varied significantly among the Tat-
responsive clones, ranging from 2- to 260-fold. There was
no correlation between the basal level of CAT activity
and the degree of transactivation by Tat.
FIG. 4. Constitutive expression from the HIV LTR in cell clones. The
Effect of different HIV-Tat proteinsCAT activity for each clone represents an average of four transfections,
each carried out in duplicate. The measured CAT units, defined as 1%
It is apparent from Fig. 5 that pCGTat, encoding Tat86,conversion of the chloramphenical form to the acetylated form in a 1-
hr reaction at 377, were normalized to equal amounts of protein. generally transactivated the integrated LTR-CAT cassette
more efficiently than pCMV-Tat, encoding Tat72. This ob-
servation is reminiscent of the report that the two-exon
and 28 not shown). To determine whether the remaining form of Tat, Tat101, transactivated much more effectively
clones contained nonrescuable integrated wild-type than Tat72 when the LTR-CAT cassette was integrated
AAV, genomic DNA from these clones was analyzed by into human (HeLa) or monkey (CV1) chromosomal DNA
Southern blotting and probed with AAV DNA (data not (Jeang, 1993). The two forms of Tat were equally effective
shown). All clones that scored negative in the rescue/ when the LTR-CAT was situated on an episome, how-
replication assay were also negative for nonrescuable ever. To determine whether Tat86 is intrinsically more
integrated wild-type AAV genome by this test. effective than Tat72 at transactivating the HIV promoter,
we measured their action on CAT expression in a tran-
Expression of the integrated LTR-CAT reporter
sient expression assay. HeLa cells were co-transfected
cassette
with pWP31 in the presence or absence of the Tat ex-
pression vectors. CAT activity was low in the absenceThe basal activity and Tat-stimulated activity of the
chromosomally integrated HIV-LTR promoter were moni- of Tat, but was increased 100-fold in the presence of
Tat (data not shown). In this assay, pCMV-Tat (encodingtored using CAT enzyme assays. Cultures of each cell
clone were transfected with salmon sperm DNA or a Tat- Tat72) consistently gave a slightly higher (1.5- to 2-fold)
transactivation of the pWP31 template than pCGTat (en-expressing plasmid and with an expression vector for
b-galactosidase to permit normalization for transfection coding Tat 86).
Even though Tat is driven by the CMV promoter in bothefficiency. Basal CAT enzyme activity varied among the
clones over a wide range (Fig. 4). Six clones exhibited pCMV-Tat and pCGTat constructs, the two plasmids are
not identical in other regions of the transcription units. Toundetectable CAT activity (data not shown) even though
the linked neomycin resistance gene was biologically determine whether these differences contribute to varia-
tions in transactivation efficiency, we tested a pair of Tatactive as evidenced by growth in medium containing
G418 (1 mg/ml). The remaining clones can be grouped expression vectors, pCMV-Tat1 (72R) and pCMV-Tat1
(86R), which differ only in the Tat coding region. Further-into three categories: low (clones 7.1, 27, 28, 2.1, 4.1, 1.1,
14, and 5), intermediate (clones 21, 24, 13, 8, 17, 5.1, 8.1, more, the Tat101 vector of Jeang et al. (1993), pTat2ex,
was tested in parallel. As compared to the empty vector2, and 26), and high (clones 11 and 22) expressors. The
basal CAT activity for individual clones was stable and (pCMV) or a transfection control lacking plasmid DNA,
each of the Tat vectors dramatically increased CAT enzymedid not vary significantly over a 6-month period, equiva-
lent to30 cell culture passages. Furthermore, no signif- activity when transfected into three representative cell
clones (Fig. 6A). The magnitude of Tat transactivation oficant variation in CAT expression was noted for individual
clones when growth was reestablished after freezing in the integrated HIV promoter varied substantially among
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FIG. 5. Activation of the integrated HIV LTR by Tat in cell clones. Cell monolayers were transfected with either pCMV-Tat (Tat72) or pCGTat
(Tat86), or without a Tat expression vector, together with pON260 (encoding b-galactosidase). The CAT activity for each clone represents an average
of four experiments, each carried out in duplicate. The measured CAT units were normalized to b-galactosidase activity to control for transfection
efficiency.
the three clones, ranging from 2.5- to 100-fold. Consistent specific site. The recombinant virus appeared to have
integrated into a single chromosomal site in each clone.with the results of Fig. 5, the degree of Tat transactivation
conferred by pCMV-Tat1 (72R) was about 20% less than The sites varied from clone to clone but integration into
the AAV-specific site on chromosome 19 was relativelythat given by pCMV-Tat1 (86R); pTat2ex was about 20%
less effective still (Fig. 6A). When tested in a HeLa cell rare, probably because of a shortage of the AAV rep
protein which was supplied by coinfection with limitingtransient expression assay with pWP31 DNA, all three of
these Tat expression vectors elicited a large stimulation amounts of wild-type AAV.
Basal promoter expression varied significantly amongof CAT activity (averaging 300-fold). In this co-transfection
assay, pCMV-Tat1 (72R) was about 10% more effective the isolated cell clones, consistent with the view that the
level of HIV gene expression is dictated by the site ofthan pCMV-Tat1 (86R) and about 20% more effective than
pTat2ex (Fig. 6B). In sum, Tat72 was somewhat more effec- proviral integration inter alia. When HIV Tat was tran-
siently expressed in these clones, the transcriptional ac-tive than Tat86 in transactivating the HIV promoter in co-
transfection assays but somewhat less effective on the tivity of the promoter increased dramatically, indicating
that the responsivity of TAR to Tat was maintained in theintegrated HIV promoter; Tat101 was not dramatically more
effective in either assay. chromosomal environment. Quantitatively, the degree of
Tat-induced transactivation of the integrated HIV pro-
moter differed significantly among the clones, implyingDISCUSSION
that the site of integration also influences the sensitivity
Stable integration of the HIV genome into chromo- of the promoter to its viral transactivator. Evidently, the
somal DNA is important for viral gene expression and integration site can influence both the activity of the HIV
propagation (Bednarik and Folks, 1992; Stevenson et al., promoter and its responsivity to activators. Such effects
1990; Zack et al., 1990). In the absence of proviral integra- may have profound consequences in the course of an
tion viral gene expression can be detected, but no pro- infection. It is also possible that deletions and (or) rear-
ductive infection ensues (Stevenson et al., 1990; Zack et rangements of the HIV promoter contribute to the differ-
al., 1990). Therefore, it is essential to examine the activity ences in expression of the integrated CAT gene among
of the HIV promoter in the context of the neighboring the clones. Such alterations are most likely to result in
chromosomal DNA. To this end, we used recombinant complete loss of CAT expression, however, and could
AAV vectors to transduce a reporter gene driven by the account for the absence of activity (even in the presence
of Tat) from 24% of the clones.HIV LTR into human chromosomes at random or into a
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FIG. 6. Transactivation of the HIV LTR by different forms of Tat. (A) Activation of the integrated HIV LTR-CAT cassette was measured in three
cell clones as in Fig. 5. (B) Activation of episomal HIV LTR-CAT expression was measured in HeLa cells transfected with 5 mg of pWP31 together
with pON260 and the Tat vector indicated. The CAT activities represents averages of duplicate transfections. The Tat expression vectors were
pCMV-Tat1(72R), pCMV-Tat1(86R), and pTat2ex (Tat101). Control transfections were carried out with or without the empty vector (pCMV).
The expression of eukaryotic genes can vary dramati- presence of an SV40 origin of replication (Kessler and
Mathews, 1991; Nahreini and Mathews, 1995). Althoughcally depending on their integration site or the activity of
neighboring chromosomal DNA (Navas et al., 1995; it is tempting to ascribe the effects reported here to inte-
gration in the proximity of cellular origins, we do notMoser et al., 1996). How might these position effects be
brought about? Precedents for both positive and negative currently have any data bearing on this hypothesis.
Jeang and co-workers reported that Tat72 and Tat101effects of chromosomal components on the activity of the
different promoters have been documented in a variety of transactivate the HIV-LTR promoter comparably when the
LTR is situated on an episome, but that Tat101 is a 10- tosystems (Adams and Workman, 1993; Almouzni et al.,
1991; Wolffe, 1994). Nucleosome positioning and modifi- 20-fold more efficient transactivator than Tat72 when the
promoter is integrated into chromosomal DNA (Jeang et al.,cation can allow transcription factors to gain access to
a chromosomal template by countering the repressive 1993). They therefore postulated a transcriptional role for
exon 2 of HIV Tat, specifically in regard to the transactiva-effect of histone–DNA interactions on promoter activity
(Almouzni et al., 1991). Nucleosomes can also function tion of the integrated promoter. We were unable to repro-
duce these findings with our cell lines although we notedas scaffold structures allowing transcription factors to
communicate more effectively (Verdin et al., 1993). Such some relatively small differences among the forms of Tat.
In our experiments, Tat86 was slightly more effective thaneffects have been demonstrated for the mouse mammary
tumor virus LTR (Archer et al., 1992) and for cellular pro- Tat72 on the chromosomally integrated promoter and
slightly less effective on the episomal promoter; Tat101 wasmoters (Jackson and Benyajati, 1993; Schild et al., 1993).
Furthermore, cellular factors such as the SWI–SNF com- less effective in both assays. Thus, our data argue against
the notion that the two-exon form of Tat is significantly moreplex in yeast and its human counterparts are involved in
chromatin remodeling, which in turn can facilitate the capable of transactivating the integrated HIV promoter than
the one-exon form.effect of transactivators (Peterson and Tamkun, 1995).
Hypermethylated regions can repress promoter activity Finally, our experiments emphasize the utility of AAV
as a suitable vector for the stable transduction of foreignand conversely hypomethylation can stimulate promoter
activity (Bird, 1992). Correspondingly, the integrated HIV genes into mammalian cells for long-term expression.
Further examination of the cell lines described herepromoter is transcriptionally inactive in the monocytic
cell line THP-1 unless the cells are treated with 5-azacyti- should throw more light on the processes governing ex-
pression of the HIV promoter in the biologically relevantdine (Mikovits et al., 1990). Both basal and Tat-activated
transcription from the HIV promoter are stimulated by the chromosomally integrated state.
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